Free Trial

Scotiabank Has Bullish Estimate for Nutrien FY2027 Earnings

Nutrien logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Scotiabank raised its FY2027 EPS forecast for Nutrien to $6.49 (from $6.11), which is notably above the consensus estimate of $5.34 per share.
  • Analyst sentiment is mixed but the stock carries an average rating of Moderate Buy and a consensus price target of C$80, with recent upgrades from Wells Fargo and Jefferies and downgrades from other firms.
  • Nutrien shares trade around C$97.86 with a market capitalization of C$47.09 billion and a P/E ratio of 21, indicating the stock is trading well above the consensus price target.
  • MarketBeat previews top five stocks to own in June.

Nutrien Ltd. (TSE:NTR - Free Report) - Research analysts at Scotiabank upped their FY2027 earnings per share (EPS) estimates for Nutrien in a report issued on Thursday, April 23rd. Scotiabank analyst B. Isaacson now anticipates that the company will post earnings of $6.49 per share for the year, up from their prior forecast of $6.11. The consensus estimate for Nutrien's current full-year earnings is $5.34 per share.

Nutrien (TSE:NTR - Get Free Report) last issued its earnings results on Wednesday, February 18th. The company reported C$1.14 EPS for the quarter. Nutrien had a return on equity of 9.13% and a net margin of 8.44%.The firm had revenue of C$5.34 billion for the quarter.

A number of other research analysts also recently commented on NTR. Wells Fargo & Company upgraded Nutrien from a "hold" rating to a "strong-buy" rating in a research note on Friday, March 13th. Jefferies Financial Group upgraded Nutrien from a "hold" rating to a "strong-buy" rating in a research note on Thursday, March 12th. BNP Paribas Exane downgraded Nutrien from a "strong-buy" rating to a "hold" rating in a research note on Monday, February 23rd. TD Securities upped their price target on Nutrien from C$72.00 to C$80.00 and gave the stock a "buy" rating in a research note on Wednesday, February 18th. Finally, UBS Group downgraded Nutrien from a "hold" rating to a "strong sell" rating in a research note on Thursday, March 26th. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of C$80.00.

Read Our Latest Analysis on NTR

Nutrien Stock Performance

Shares of TSE NTR opened at C$97.86 on Monday. The business's 50-day moving average price is C$102.49 and its two-hundred day moving average price is C$91.45. The company has a debt-to-equity ratio of 51.16, a current ratio of 1.34 and a quick ratio of 0.65. Nutrien has a one year low of C$73.99 and a one year high of C$116.95. The company has a market capitalization of C$47.09 billion, a P/E ratio of 21.00, a price-to-earnings-growth ratio of 1.15 and a beta of 0.99.

About Nutrien

(Get Free Report)

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

Featured Stories

Earnings History and Estimates for Nutrien (TSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines